CAH vs. COR, MCK, ICLR, RMD, WST, ZBH, MOH, ALGN, BIIB, and STE
Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include Cencora (COR), McKesson (MCK), ICON Public (ICLR), ResMed (RMD), West Pharmaceutical Services (WST), Zimmer Biomet (ZBH), Molina Healthcare (MOH), Align Technology (ALGN), Biogen (BIIB), and STERIS (STE). These companies are all part of the "medical" sector.
Cencora (NYSE:COR) and Cardinal Health (NYSE:CAH) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, community ranking, earnings, risk and media sentiment.
Cencora has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500. Comparatively, Cardinal Health has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500.
Cencora has a net margin of 0.69% compared to Cencora's net margin of 0.30%. Cardinal Health's return on equity of 323.23% beat Cencora's return on equity.
Cencora pays an annual dividend of $2.04 per share and has a dividend yield of 0.9%. Cardinal Health pays an annual dividend of $2.00 per share and has a dividend yield of 1.8%. Cencora pays out 22.2% of its earnings in the form of a dividend. Cardinal Health pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cardinal Health has increased its dividend for 27 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Cencora currently has a consensus target price of $214.90, suggesting a potential downside of 10.20%. Cardinal Health has a consensus target price of $103.07, suggesting a potential downside of 6.42%. Given Cencora's higher probable upside, analysts clearly believe Cardinal Health is more favorable than Cencora.
93.1% of Cencora shares are owned by institutional investors. Comparatively, 86.0% of Cardinal Health shares are owned by institutional investors. 15.8% of Cencora shares are owned by insiders. Comparatively, 0.2% of Cardinal Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
In the previous week, Cardinal Health had 1 more articles in the media than Cencora. MarketBeat recorded 12 mentions for Cardinal Health and 11 mentions for Cencora. Cencora's average media sentiment score of 0.97 beat Cardinal Health's score of 0.36 indicating that Cardinal Health is being referred to more favorably in the news media.
Cencora has higher revenue and earnings than Cardinal Health. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.
Cardinal Health received 163 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 71.66% of users gave Cardinal Health an outperform vote while only 65.03% of users gave Cencora an outperform vote.
Summary
Cencora beats Cardinal Health on 11 of the 21 factors compared between the two stocks.
Get Cardinal Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Cardinal Health Competitors List
Related Companies and Tools